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ABSTRACT
Puerperal uterine infections are often associated with 
decreased reproductive performance in dairy cows. 
Routine treatment protocols include the systemic ad-
ministration of antibiotics. Antibiotic drugs, however, 
should be administered daily over at least 5 d. The ob-
jective of this study was to determine concentrations of 
ceftiofur derivatives in serum, endometrial tissue, and 
lochia after subcutaneous administration of ceftiofur 
crystalline free acid in 6 clinically healthy puerperal 
dairy cows with normal parturition. Samples were tak-
en immediately before treatment, 2 h after, and then 
every 24 h over a 7-d period. Concentrations of ceftio-
fur derivatives were quantified using an HPLC assay. 
In serum and endometrial tissue, ceftiofur derivatives 
could be detected above the reported minimum drug 
concentrations required to inhibit relevant pathogens 
such as Escherichia coli and Arcanobacterium pyogenes 
over a 7-d period. Concentrations of desfuroylceftio-
furacetamide at 5 d after administration of ceftiofur 
crystalline free acid were 1.21 ± 0.61 μg/mL in serum, 
0.86 ± 0.61 μg/mg in endometrial tissue, and 0.96 ± 
1.15 μg/mL in lochia. In lochia, mean concentrations of 
ceftiofur derivatives also remained above the minimal 
inhibitory concentration of relevant pathogens, but 
showed greater variations between cows.
Key words:  ceftiofur crystalline free acid, minimum 
inhibitory concentration, dairy cow, puerperal endo-
metritis
INTRODUCTION
Puerperal uterine infections such as metritis and 
endometritis are common problems in high-producing 
dairy cows (Galvão et al., 2009) and often associated 
with decreased reproductive performance (Gilbert et 
al., 2005). Uterine function can be compromised by 
bacterial contamination of the uterus after parturition. 
Relevant pathogens often persist and lead to uterine 
infections, which can cause infertility (Sheldon et al., 
2006). The most common bacteria found in postpartum 
uterine diseases in cows are Escherichia coli, Arcanobac-
terium pyogenes, and aerobic species such as Fusobacte-
rium necrophorum and Prevotella melaninogenica (Shel-
don and Dobson, 2004). A common method to reduce 
the effect of uterine infection on fertility is intrauterine 
or systemic treatment with antibiotics (Galvão et al., 
2009). The use of a local antibiotic treatment, however, 
is controversial (Drillich et al., 2001). Adverse interac-
tions of the antibiotic drug and the uterine environ-
ment, irritation of the endometrium by the antibiotic 
drug itself or the carrier substance, and a limited ef-
ficacy of the antibiotics within the inflamed tissue make 
local treatment with antibiotics questionable (Paisley 
et al., 1986). In the last decade, efficacy of intervention 
strategies based on the systemic application of broad-
spectrum antibiotics has been demonstrated repeatedly 
(Smith et al., 1998; Drillich et al., 2006a; Galvão et al., 
2009).
Ceftiofur is a third-generation cephalosporin, an im-
portant class of antimicrobial drugs used in veterinary 
medicine (Hornish and Kotarski, 2002). Good efficacy 
of ceftiofur for treatment of retained fetal membranes 
(RFM; Drillich et al., 2006a, b) and acute puerperal 
metritis (APM; Drillich et al., 2001) has been dem-
onstrated. Furthermore, intrauterine infusion of ceft-
iofur hydrochloride positively affected uterine health 
in dairy cows but failed to decrease the incidence of 
subclinical endometritis or improve reproductive per-
formance (Galvão et al., 2009). Ceftiofur is a highly 
effective drug against almost all gram-positive and 
gram-negative pathogens (Salmon et al., 1996; Haggett 
and Wilson, 2008). In the liver, it is hydrolyzed to des-
furoylceftiofuracetamide (DCA), an active metabolite 
that is protected from fast renal elimination through 
protein binding (Brown et al., 1991). Desfuroylceftio-
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furacetamide reaches maximum plasma concentrations 
2 h after i.m. and 3 h after s.c. administration with a 
half-life of 9.65 ± 1.97 h in calves (Brown et al., 2000). 
Science-based evidence shows that concentrations of 
DCA in the endometrium of puerperal cows exceed the 
reported MIC for E. coli (0.5 μg/mL) and A. pyogenes 
(0.125 μg/mL) after a single (Okker et al., 2002) or 3 
consecutive (Drillich et al., 2006b) s.c. administrations, 
respectively. In single samples, however, the concentra-
tion decreased below the MIC for E. coli (Drillich et al., 
2006b). Similarly, concentrations of ceftiofur remained 
above the reported MIC for relevant equine pathogens 
such as Streptococcus zooepidemicus in both serum 
and endometrial tissue until 24 h after treatment of 
healthy mares (Witte et al., 2010). In cows with signs 
of clinical endometritis diagnosed between 21 and 28 
d postpartum, however, the systemic treatment with 
ceftiofur on 3 consecutive days had the same effect as 
a treatment protocol using 2 doses of cloprostenol in a 
14-d interval (Kaufmann et al., 2010). In the first 3 wk 
after parturition, however, infections of the uterus are 
seldom restricted to the endometrium. Therefore, par-
enteral administration of antibiotics is recommended 
to provide adequate drug concentrations in all uterine 
tissues (Bretzlaff et al., 1983).
Cephalosporins have a clinical efficacy, which depends 
on the time during which drug concentrations remain 
above the MIC of the pathogen. In a study of Sheldon 
et al. (2004), the MIC of commonly used antibiotics 
for principal bacteria associated with uterine infections 
were evaluated. In the present study, we refer to the 
MIC values of E. coli (MIC90 = 0.5 μg/mL), A. pyo-
genes (MIC90 = 0.125 μg/mL), F. necrophorum (MIC90 
= 0.125 μg/mL), and P. melaninogenica (MIC90 = 0.125 
μg/mL; Sheldon et al., 2004). It is, therefore, important 
to demonstrate that levels of the active metabolite are 
maintained above the MIC of target pathogens for an 
adequate period (Drillich et al., 2001, 2006b; Chenault 
et al., 2004). In the United States and Europe, ceftiofur 
(Excenel RTU, Pfizer Animal Health, New York, NY 
and Pfizer Animal Health, Berlin, Germany, respec-
tively) has been approved for the treatment of APM 
for 5 consecutive days. Anecdotal evidence from the 
field, however, suggests that on average only 2 to 3 
treatments are administered for therapy of feverish 
metritis. It is unknown if a shortened time above MIC 
causes suboptimal cure rates, poses a risk for subclinical 
endometritis, and reduces reproductive performance. 
Therefore, an intervention based on a single injection 
of a long-acting formulation to administer an effective 
treatment of APM would be advantageous.
Ceftiofur crystalline free acid (CCFA, Naxcel, Pfizer 
Animal Health, Berlin, Germany) is a sustained-release 
formulation of ceftiofur that is approved for acute 
bovine interdigital necrobacillosis. After s.c. adminis-
tration at the base of the ear, it sustained effective 
serum concentrations over a 7.6-d period (Hibbard et 
al., 2004).
The objective of the present study was to determine 
concentrations of DCA in puerperal dairy cows after a 
single s.c. administration of CCFA over a period of 7 d. 
The hypothesis to be tested was that the concentration 
of DCA determined in serum, endometrial tissue, and 
lochia after a single s.c. injection of 6.6 mg/kg of BW 
of CCFA at the base of the ear exceeded the reported 
MIC for E. coli and A. pyogenes, F. necrophorum, and 
P. melaninogenica for a 7-d period.
MATERIALS AND METHODS
Experimental Animals and Design
The study was conducted between January and 
April 2010 at the Clinic for Animal Reproduction, Fac-
ulty of Veterinary Medicine, Freie Universität Berlin, 
Germany. A total of 6 healthy Holstein-Friesian cows 
was included in the study (5 cows expelled their fetal 
membranes within 12 h, 1 cow had retained fetal mem-
branes). Cows were housed at the Clinic for Animal 
Reproduction in a tie-stall barn with straw bedding 
from 14 ± 10 d before parturition until the end of the 
study. Parturition occurred spontaneously. During 14 d 
before parturition and until the end of the study, none 
of the cows enrolled received antibiotics or antiinflam-
matory drugs other than CCFA.
The study period was defined as the time from col-
lection of the baseline samples until collection of the 
last samples; that is, 7 d after administration of CCFA. 
Twelve to 24 h after calving, cows received a single dose 
of 6.6 mg/kg of BW of CCFA s.c. at the base of the ear. 
Immediately before administration, baseline samples of 
serum, endometrial tissue, and lochia were collected. 
Additional blood, tissue, and lochia samples were taken 
within 2 h ± 30 min after administration of CCFA and 
then every 24 h ± 1 h for 7 d.
Methods of Sampling
Before taking the samples, rectal temperature was 
measured with a digital thermometer (Microlife AG, 
Heerbrugg, Switzerland). Blood samples were collected 
from coccygeal vessels using sterile vacuum tubes 
(Venoject II, Termumo Europe N.V., Leuven, Bel-
gium). Before further processing of the blood samples, 
BHBA was detected using an electronic BHBA measur-
ing system (Precision Xtra, Abbott, Abingdon, UK), 
as described previously (Iwersen et al., 2009). Within 
30 min after sampling, blood samples were centrifuged 
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at 3,500 × g for 8 min at room temperature and serum 
stored at −20°C until further analysis.
Before collection of samples from the uterus, the 
perineum was washed 3 times with a disinfectant soap 
and dried with paper towels. Biopsy samples were 
taken from the base of either uterine horn with a Kev-
orkian biopsy forceps (WDT, Garbsen, Germany), as 
described for horses (modified after Ricketts, 1975). 
In brief, the biopsy forceps was manually introduced 
through the spread vulva into the vagina and into or 
through the cervical canal. The hand was removed and 
the biopsy forceps was placed at the base of one uterine 
horn through rectal control. A sample of uterine tissue 
(approximately 0.15 g) was collected under transrectal 
control. The collected tissue was stored in sterile plastic 
tubes (Eppendorf, Hamburg, Germany) at −20°C until 
further analysis.
Finally, one sterile-gloved hand or an insemination 
pipette was introduced through the vagina into the 
uterine lumen and at least 3 mL of lochia was collected. 
Within 30 min after collection, lochia samples were 
stored in 10-mL plastic tubes (Eppendorf) at −20°C 
until further analysis.
Additionally, from one healthy, nontreated cow, 100 
mL of serum, 10 g of endometrial tissue, and 100 mL of 
lochia were collected within 24 h after calving as blank 
material for HPLC analysis.
Analytical Methods
Concentrations of ceftiofur (molecular weight = 
523.56 g/mol) residues were quantified in serum, en-
dometrial tissue, and lochia samples using an HPLC 
assay as described by Drillich et al. (2006b) and Witte 
et al. (2010). In this method, residues of ceftiofur were 
converted into DCA (molecular weight = 486.54 g/
mol), which was determined by HPLC.
Briefly, 1.0 mL of serum or lochia or 0.1 g of en-
dometrium was mixed with 5.0 mL of dithioerythritol 
solution (20 mg/mL dithioerythritol solution in 50 mM 
potassium tetra borate buffer containing 0.5 M sodium 
chloride) at pH 9. Endometrial tissue was homogenized 
using an Ultra-Turrax homogenizer (IKA, Staufen, 
Germany) for 30 s. All following steps in sample treat-
ment were carried out as described in Drillich et al. 
(2006b). For HPLC analysis, 50 μL injections were 
made on an Inertsil ODS-2 column (200 × 3 mm, Varian 
Medical Systems, Houten, the Netherlands). A gradient 
program was run by an HPLC pump (Merck-Hitachi, 
Tokyo, Japan) mixing 10 mM ammonium acetate in 
water (eluent A) and acetonitrile (eluent B) at a flow 
rate of 0.40 mL/min. The gradient started with 99% A 
for 1.9 min, to 92% A in 0.1 min, to 82% A in 12 min, 
to 0% A in 1 min and held at 0% A for 7 min. Then, 
the column was equilibrated for 8 min, resulting in a 
total run time of 30 min. The eluate of the column was 
monitored using a UV detector (Applied Biosystems, 
Foster City, CA) operated at 266 nm. Chromatograms 
were recorded onto a computer running ChromQuest 
version 2.51 (Thermo, Breda, the Netherlands). Stan-
dards for quantification were prepared by processing 
blank serum spiked with ceftiofur in a range of 0.05 to 
10.0 μg/mL. These samples were processed together at 
the same time with real study samples.
For analysis of the endometrial tissue an additional 
liquid chromatography tandem MS was performed. In 
brief, 10-μL injections were made into an HPLC system 
consisting of 2 HPLC pumps (PE200 series, Perkin-El-
mer, Waltham, MA), an autosampler (CTC Analytics, 
Zwingen, Switzerland), and an API4000 MS detector 
with an electrospray interface (Applied Biosystems). 
Eluent A was 10 mM ammonium acetate in water and 
eluent B was acetonitrile. The flow rate was 200 μL/
min and a gradient was set as follows: 99% A for 2 min, 
then switched to 92% A, followed by a linear gradient 
to 30% A in 10 min, held at 30% A for 3 min, and back 
to the initial situation. The column was equilibrated 
with 99% A for 4 min. The electrospray voltage was 
set at 5,000 V, and the entrance and declustering volt-
ages were set at 10 and 74 V, respectively. Tandem MS 
analysis was performed in positive multiple reaction 
monitoring mode between 2 and 12 min after injection. 
The liquid chromatography tandem MS instrument was 
controlled by Analyst software (version 1.4.2, Applied 
Biosystems). Standards for quantification were pre-
pared by spiking blank material. These samples were 
processed together at the same time with real study 
samples.
Limit of detection of this method was 0.1 μg/mL of 
ceftiofur for serum and lochia and 0.1 μg/g of ceftiofur 
for endometrial tissue, respectively, as described in for-
mer studies (Drillich et al., 2006b).
Statistical Analyses
All data were recorded on data capture forms and 
transferred into a spreadsheet (Excel 2003, Microsoft, 
Munich, Germany). Descriptive statistical analyses were 
carried out with the SPSS statistic package (SPSS for 
Windows 16.0, SPSS Inc., Munich, Germany). Results 
are presented as means ± standard error of mean. Level 
of significance was set at a P-value < 0.05.
Correlations between concentrations of DCA in se-
rum, endometrial tissue, and lochia were tested using 
the Spearman rank correlation (rs) for nonparametric 
variables.
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RESULTS
Average gestation length of 5 cows was 280 ± 6 d. 
The remaining cow calved 3 wk before the calculated 
date of calving. Parturition occurred normally without 
intervention in all cows. All cows except one expelled 
the fetal membranes within 24 h after calving. Only one 
animal had a case of RFM. In all animals, samples were 
collected until 6 d after treatment. In 4 animals, ad-
ditional samples were collected at 7 d after treatment.
Mean rectal temperature and mean concentration of 
BHBA of all cows for the whole observation period was 
38.8 ± 0.2°C and 0.9 ± 0.4 mmol/L, respectively. Only 
5 and 6 measurements exceeded 39.4°C and 1.4 mmol/L 
of BHBA, respectively.
The greatest DCA concentrations in serum were de-
tected at 24 and 48 h after administration of CCFA 
in 50% of the cows (Table 1). Serum concentrations 
remained above the reported MIC of 0.5 μg/mL for E. 
coli during the entire observation period (Figure 1). In 
a few serum samples concentrations of DCA decreased 
below 0.5 μg/mL at 5 d (n = 1), 6 d (n = 1), and 7 d 
(n = 2) after administration of CCFA (Table 2). The 
concentrations of DCA in serum, however, remained 
above the MIC for A. pyogenes, F. necrophorum, and P. 
melaninogenica (0.125 μg/mL) for the entire observa-
tion period in all cows.
In endometrial tissue, mean concentrations of DCA 
remained above the MIC for E. coli, A. pyogenes, F. 
necrophorum, and P. melaninogenica during the en-
tire observation period (Table 1; Figure 1). In 1 cow, 
however, concentrations of DCA decreased below the 
reported MIC for A. pyogenes, F. necrophorum, and P. 
melaninogenica at 6 d and in 2 cows below the reported 
MIC for E. coli, respectively, 5 and 6 d after administra-
tion of CCFA (Table 2). Mean concentration of DCA in 
endometrial tissue peaked 24 h after administration of 
CCFA and decreased until 7 d after treatment.
In lochia, DCA concentrations varied more widely. 
Mean concentrations of DCA in lochia exceeded the 
threshold values of 0.125 μg/mL (A. pyogenes, F. 
necrophorum, and P. melaninogenica) and 0.5 μg/mL 
(E. coli), respectively, until 6 d after administration 
of CCFA (Table 1; Figure 1). Mean concentrations 
were greatest 2 h after treatment. In individual cows, 
threshold values were not reached at certain time points 
(Table 2).
A highly significant positive correlation was found 
between concentrations of DCA in serum and endome-
trial tissue (rs = 0.979; P < 0.001). The correlations 
between serum and lochia, and between endometrial 
tissue and lochia were considerably lower (rs = 0.32 and 
rs = 0.48, respectively, P > 0.05).
Concentrations of DCA measured in one cow with 
a case of RFM did not show differences compared 
with those in cows that expelled their fetal membranes 
within 12 h after calving until 5 d after administra-
tion of CCFA. Six days after administration of CCFA, 
however, concentrations of DCA in this cow decreased 
below the reported MIC for relevant pathogens (Table 
2). Rectal temperatures of this cow increased on d 3 
and 4 (40.0 and 39.6°C), respectively.
DISCUSSION
Treatment of puerperal uterine infections with sys-
temic administration of antibiotics represents a widely 
accepted intervention in dairy cows (Brown et al., 2000; 
Okker et al., 2002; Drillich et al., 2006a). Ceftiofur has 
been reported to be the most commonly used antibiotic 
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Table 1. Concentrations of desfuroylceftiofuracetamide (DCA; mean ± SEM)1 in serum, endometrial tissue, 
and lochia before (0) and 2 to 168 h after administration of ceftiofur crystalline free acid (CCFA; 6.6 mg/kg 
of BW) 
Time after  
administration  








0 6 0.10** 0.20* 0.10**
2 6 1.11 ± 0.70 1.18 ± 1.16 9.79 ± 17.42
24 6 4.15 ± 1.63 2.33 ± 1.63 3.53 ± 4.46
48 6 3.38 ± 0.78 1.97 ± 0.47 5.88 ± 7.30
72 6 2.50 ± 0.98 1.49 ± 0.67 2.15 ± 2.57
96 6 1.54 ± 0.68 1.19 ± 0.47 2.61 ± 3.89
120 6 1.21 ± 0.61 0.86 ± 0.61 0.96 ± 1.15
144 6 0.82 ± 0.42 0.70 ± 0.68 2.44 ± 3.46
168 4 0.55 ± 0.29 0.58 ± 0.10 0.28 ± 0.29*
1MIC90 for Escherichia coli <0.5 μg/mL; MIC90 for Arcanobacterium pyogenes, Fusobacterium necrophorum, 
and Prevotella melaninogenica <0.125 μg/mL.
*Values below the MIC for E. coli; **values below the MIC for A. pyogenes, F. necrophorum, and P. melani-
nogenica.
drug in bovine practice (Zwald et al., 2004; Sawant et 
al., 2005). In the United States and Europe ceftiofur 
has been approved for the treatment of cows with acute 
postpartum metritis, bovine respiratory disease, and 
bovine interdigital necrobacillosis. Label instructions 
require treatment on 5 consecutive days. A survey on 
antibiotic usage conducted on 113 dairy farms identi-
fied failure to complete antimicrobial treatment course 
in 76% of the responding herds (Sawant et al., 2005). 
According to anecdotal evidence the administration of 
systemic antibiotic drugs is often reduced to 2 to 3 d for 
practical or economic reasons. In addition to the abbre-
viated use of antimicrobials, the reliability on personal 
experience for antibiotic use and dosage could lead to 
inappropriate antibiotic usage (Sawant et al., 2005). 
Although a change to another antibiotic drug in case 
of resistance is not possible, a long-acting antibiotic 
drug approved for the treatment of uterine diseases in 
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Figure 1. Concentrations of desfuroylceftiofuracetamide (DCA) in serum, endometrial tissue, and lochia before (0) and 2 to 168 h after 
administration of ceftiofur crystalline free acid (6.6 mg/kg of BW) Asterisk denotes an outlier before treatment. 
Table 2. Number of samples with concentrations of desfuroylceftiofuracetamide (DCA) <0.5 and <0.125 
μg/mL (serum and lochia)1 or <0.5 and <0.125 μg/g (endometrial tissue)1 after administration of ceftiofur 




Time after administration of CCFA (h)
2 24 48 72 96 120 144 168
Serum <0.5 — — — — — 1/62 1/62 2/42
 <0.125 — — — — — — — —
Endometrium <0.5 1/5 — — — — 2/62 2/62 —
 <0.125 1/5 — — — — — 1/62 —
Lochia <0.5 2/5 1/6 1/6 — 2/6 3/6 3/52 3/42
 <0.125 2/5 1/6 — — 1/6 2/6 2/52 2/42
1MIC90 for Escherichia coli <0.5 μg/mL; MIC90 for Arcanobacterium pyogenes, Fusobacterium necrophorum, 
and Prevotella melaninogenica <0.125 μg/mL.
2One sample from one cow with retained fetal membranes included.
cows would be advantageous from a practical, economic 
(Galligan, 2006), and prudent drug use perspective. 
The objective of the present study was to determine 
concentrations of ceftiofur derivatives in serum, endo-
metrial tissue, and lochia after one s.c. administration 
of CCFA, a sustained-release formulation of ceftiofur, 
in healthy puerperal dairy cows.
Time above the MIC is the pharmacokinetic (PK) 
parameter most associated with efficacy for this class 
of antibiotics. Overall, mean concentration of DCA in 
serum, uterine tissue, and lochia remained above the 
reported MIC for common uterine pathogens of 0.5 μg/
mL for E. coli (Sheldon et al., 2004) during the entire 
study period of 7 d. In single samples, however, 6 and 
7 d after administration of CCFA, concentrations of 
DCA decreased to <0.5 μg/mL (1, 2, 3 and 2, 0, 3 
samples in serum, endometrial tissue, and lochia on d 
6 and 7, respectively; Table 2). Concentrations of DCA 
in serum remained above the MIC for A. pyogenes, F. 
necrophorum, and P. melaninogenica during the entire 
observation period. Concentrations of DCA in endome-
trial tissue decreased below 0.125 μg/mL in only one 
cow at d 6. Thus, only in few instances, suboptimal 
antibiotic concentrations occurred. As it is known that 
true tissue concentrations, especially of water-soluble 
antibiotics, are underestimated due to dilution in the 
extracellular fluid during the analytical process (Brown 
et al., 1995), in vivo and in vitro efficacy of antibiotics 
may differ. Thus, true antibiotic concentrations also 
may be underestimated in the present study.
Pharmacokinetic data of ceftiofur hydrochloride 
have been described after s.c. and i.m. administration 
in healthy dairy cows (Brown et al., 2000; Okker et 
al., 2002). Several studies demonstrated that active 
metabolites of ceftiofur hydrochloride exceeded the 
reported MIC of uterine pathogens for 24 h in cows 
(Brown et al., 2000; Okker et al., 2002; Drillich et al., 
2006b) and mares (Witte et al., 2010). Additionally, a 
recent study demonstrated the efficacy of 3 consecutive 
administrations of ceftiofur hydrochloride in cows with 
RFM (Drillich et al., 2006a).
A single administration of CCFA has been dem-
onstrated to be clinically efficacious for treatment of 
acute bovine interdigital necrobacillosis and to achieve 
serum DCA concentrations above the MIC of relevant 
pathogens for 6 d (Van Donkersgoed et al., 2008). The 
present study is the first providing PK data on con-
centrations of active metabolites in lochia and uterine 
tissue after administration of CCFA at a single dose of 
6.6 mg/kg of BW.
Pharmacokinetic data of CCFA were different com-
pared with those described for ceftiofur hydrochloride. 
Okker et al. (2002) and Drillich et al. (2006b) found 
a first maximum of ceftiofur derivatives in serum and 
endometrial tissue 2 h after treatment, whereas in our 
study, greatest DCA concentrations were reached 24 h 
after administration. This can be explained by the slow 
release characteristic of the CCFA formulation. Addi-
tionally, maximum values found in the present study 
in serum (4.15 ± 1.63 μg/mL) and endometrial tissue 
(2.33 ± 1.63 μg/g) were greater than the maximum 
values reported by Okker et al. (2002; 2.85 μg/mL and 
2.23 μg/g) and Drillich et al. (2006b; 1.66 μg/mL and 
2.02 μg/g).
For lochia, results were more heterogeneous. This is 
in agreement with previous studies (Okker et al., 2002; 
Drillich et al., 2006b) as well. The lower concentrations 
of DCA in lochia compared with those in serum and 
endometrial tissue may occur due to a dilution of lochia 
with the remaining fluid within the uterus after par-
turition (Okker et al., 2002). Mean concentrations of 
DCA in lochia, however, decreased below the MIC for 
E. coli (0.5 μg/mL) only 7 d after administration and 
stayed above the MIC for A. pyogenes, F. necrophorum, 
and P. melaninogenica (0.125 μg/mL) during the whole 
observation period (Table 1). Thus, concentrations of 
DCA measured in lochia in the present study are likely 
to be effective against relevant pathogens. The large 
variations of DCA concentrations in lochia contributed 
to the moderate correlations of concentrations in lochia 
compared with serum and endometrial tissue.
In the present study, relationships between rectal 
temperature and ceftiofur derivatives in serum, en-
dometrial tissue, and lochia were not detected as has 
been described in former studies (Drillich et al., 2006b). 
As rectal temperature was measured every 24 h im-
mediately before, but not after, sampling, the effect of 
intrauterine manipulation due to sampling could not 
be demonstrated. An increase of rectal temperature 
as shown by other authors 2 and 4 h after sampling 
(from 38.8°C to 39.2°C; Drillich et al., 2006b) could not 
be shown in the present study. Therefore, no evidence 
exists that temperature increases due to the sampling 
procedure. Another explanation could be that an in-
creased ceftiofur concentration leads to a release of 
pyretic toxins due to the increased bactericidal poten-
tial of the antimicrobial drug (Drillich et al., 2006b). In 
the present study, however, rectal temperatures were 
lowest at the time of greatest DCA concentrations in 
serum and endometrial tissue.
This study provides the first evidence that concen-
trations of ceftiofur derivatives in serum, endometrial 
tissue, and lochia of healthy puerperal dairy cows re-
mained above the MIC of common uterine pathogens 
over a 7-d observation period after s.c. administration 
of 6.6 mg/kg of BW CCFA. Only in single samples, 6 
and 7 d after administration of CCFA, concentrations 
decreased below the reported MIC of relevant patho-
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gens, which would temporarily lead to suboptimal drug 
concentrations. Furthermore, concentrations of DCA 
decreased below the MIC already 5 d after administra-
tion of CCFA in one cow with RFM. Further research is 
warranted to investigate PK data after one administra-
tion of CCFA in cows with postpartum uterine diseases 
(e.g., RFM, APM).
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